Biotech investing is often a high-risk, high-reward game, with clinical trial results capable of sending stocks soaring or ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best biotech stocks with high potential. In a report released on ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

In this article, we will look at the 14 Best Biotech Penny Stocks to Buy Right Now. Is The Biotech Sector Ready for a Breakout? On July 8, Mizuho’s healthcare strategist Jared Holz appeared on CNBC’s ...

Insider buying has been slow this month, as buy windows close ahead of the new earnings-reporting season. However, there have been some notable, large purchases nonetheless. That includes at a couple ...

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech ...

Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, ...

As we near the end of the ongoing earnings season, the scorecard for the Medical sector appears pretty decent. The sector primarily comprises pharma/biotech and medical device companies. Almost all ...

A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking’s Momentum scores over the past week alone. Top 3 Biotech Stocks With A Big Surge In Momentum ...

Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read ...